Dr. Ian Cooke, a urologist with Kaiser Permanente, joined KCRA 3 to talk about prostate cancer.

Conversations around prostate cancer are front and center after former President Joe Biden announced he was diagnosed with an "aggressive" form of the disease.

The accuracy of prostate-specific antigen (PSA ... Memorial Sloan Kettering Cancer Center, Skåne University Hospital in Sweden, Kaiser Permanente Northern California, the University of Southern ...

Prostate cancer remains a significant health concern for older men, often presenting symptoms such as difficulty urinating and bodily pain. With former ...

Patients with intermediate-risk prostate cancer had a 15-year prostate cancer–specific ... Goy, radiation oncologist at Kaiser Permanente Los Angeles Medical Center, wrote in the poster. “It is ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

S2,3PSA% as a predictor of reclassification of 1st protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study. The nature of progression on long term ...